Prof. Fuad Fares, Dr. Lital Sharvit and Prof. (Emeritus) Solomon Wasser (Faculty of Natural Sciences) have developed a novel cancer treatment that utilizes extracts of Cyathus striatus mushrooms to reduce tumors in animals without damaging healthy tissues. CanCurX, a startup founded by Carmel* together with the researchers, has partnered with the Israeli biomedical company Cannabotech to develop plant-based cancer botanical drugs based on fungal extracts. The agreement allows the use of a patent for developing drugs that are fungal based. Cannabotech will fund the development, which will be conducted in part at University of Haifa labs. The companies hope that their combined products will help treat cancer patients in the future.*Carmel is the University of Haifa’s economic company and founder of Carmel Innovations Funds I and II. READ MORE IN THE JERUSALEM POST
*Credit: Getty Images
In the News Credit: Hagai Nativ/Morris Kahn Marine Research Station A novel research study conducted at Eilat’s dolphin reef has revealed that ship noises disrupt
In the News Interest in post-traumatic stress disorder (PTSD) has surged since the Gaza war outbreak. Traumatic memories can resurface years later, disrupting the lives
In the News (l-r) Dr. Yifat Aran and Prof. Oren Gazal-Ayal Congratulations to Prof. Oren Gazal-Ayal and Dr. Yifat Aran on being awarded the prestigious Cheshin
© Division of the Presidency and External Relations